Practice
Featured experience
InSilico Medicine HK$2.62 billion IPO
We advised InSilico Medicine on its IPO and HKEX listing
Mastercard $1.8 billion acquisition of BVNK
We are advising Mastercard on the transaction
Sycamore Partners up to $23.7 billion acquisition of Walgreens Boots Alliance
We are advising Sycamore Partners on the transaction
Comcast spinoff of select cable television networks
We are advising Comcast on the transaction
Valaris $400 million senior secured second-lien notes offering
The high-yield senior secured second-lien notes are due 2030
Fiserv $2 billion notes offering
The investment-grade debt consists of two tranches of notes
Apollo Global Management $2.625 billion Arconic acquisition financing
We advised the agent and lenders on the financing
Akamai Technologies $1.1 billion convertible senior notes offering
The convertible senior notes are due 2029
Workiva $625 million convertible senior notes offering
The 1.25% convertible senior notes are due 2028
Shockwave Medical $750 million convertible senior notes offering
The 1% convertible notes are due 2028
Fluor $115 million tender offer
The company purchased certain debt securities
Cano Health amendment and covenant waiver for side-car credit facility
We advised Rubicon Founders in connection with the transaction
Toyota Motor Credit $650 million diversity and inclusion notes offering
We advised the company on the SEC-registered notes offering
SSI Strategy acquisition of NDA Group
We advised SSI Strategy on the acquisition